Korea United Pharm. Inc. is a prominent multinational pharmaceutical manufacturer and distributor headquartered in Seoul, South Korea. Established in 1987 and publicly traded, the company has grown into a global leader in the development of modified new drugs (IMDs). With a workforce of 501 to 1,000 employees, the organization operates advanced manufacturing facilities, including a smart factory built in 2017 and a PIC/s GMP-certified production site in Vietnam. The company specializes in a diverse portfolio of over 200 medicinal products, including anticancer drugs, antibiotics, gastrointestinal treatments, and circulatory system medications. Notable proprietary formulations include Silostan CR, Gastin CR, and Clanza CR. Their R&D capabilities focus on high-level formulation technology, drug delivery systems, and quality enhancement through the QbD system. Korea United Pharm. Inc. maintains a significant international footprint, exporting finished pharmaceuticals to over 60 countries and operating overseas branches in Vietnam, the Philippines, Myanmar, Indonesia, and Thailand. The company offers OEM services and holds a strong market position in both prescription (ETC) and over-the-counter (OTC) segments, supported by its '20 Million Dollar Export Tower' recognition.
OPV Pharmaceutical Joint Stock Company is a premier pharmaceutical manufacturer and distributor based in Bien Hoa, Vietnam. Founded in 1950, the company has grown into one of Vietnam's most established pharmaceutical enterprises and is now a key member of the multinational RV Group. Operating from a state-of-the-art 50,000 sqm facility, the company employs between 301 and 500 professionals and maintains a diverse portfolio of over 840 registration numbers, the most extensive in the country. OPV specializes in both Ethical (ETC) and Over-The-Counter (OTC) products, with core therapeutic areas including analgesics, antipyretics, antibiotics, vitamins, dermatology, and gastrointestinal medicines. Their manufacturing capabilities are highly advanced, utilizing 'Blow-Fill-Seal' technology for sterile products and producing various dosage forms such as oral solids, liquids, creams, and injectables. The company is a trusted partner for global multinational corporations, offering comprehensive Contract Manufacturing (CMO), ODM, and OEM services. Their facilities adhere to rigorous international quality standards, holding certifications including EU-GMP, WHO-GMP, PIC/S, ISO 9001, ISO 14001, and ISO 45001. With a long history of strategic partnerships with industry leaders like GSK, MSD, and Johnson & Johnson, OPV Pharmaceutical continues to be a leader in the ASEAN pharmaceutical market, providing high-quality healthcare solutions for both local and international markets.